CROSS DEEP SURGERY
CROSS DEEP SURG & MED CTR, 4 CROSS DEEP, TWICKENHAMCKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 230 | 247 | 93.1% | |
CKD 4 | 2008 | 307 | 329 | 93.3% | |
CKD 5 | 2009 | 37 | 37 | 100.0% | |
CKD 5 | 2010 | 3 | 3 | 100.0% | |
CKD 5 | 2011 | 3 | 3 | 100.0% | |
CKD 5 | 2012 | 3 | 3 | 100.0% | |
CKD 5 | 2013 | 3 | 3 | 100.0% | |
CKD003 | 2014 | 3 | 3 | 100.0% | |
CKD003 | 2015 | 3 | 3 | 100.0% | |
NM84 | 2016 | 4 | 4 | 100.0% | |
NM84 | 2017 | 5 | 5 | 100.0% | |
NM84 | 2018 | 5 | 6 | 83.3% | |
NM84 | 2020 | 5 | 8 | 62.5% | |
NM84 | 2022 | 4 | 9 | 44.4% | |
NM84 | 2023 | 7 | 12 | 58.3% |